ACS Clinical Research Program
The evolving clinical management of sentinel node-positive melanoma: The impact of MSLT-II on clinical practice(0)
The results of the Multicenter Selective Lymphadenectomy Trial-II as they relate to treatment recommendations for melanoma patients with a positive sentinel lymph mode biopsy are summarized.
Ongoing and future clinical trials examining how liquid biopsies may be a promising tool for early cancer diagnosis, prognosis, and recurrence are the focus of this month’s column.
The importance of identifying high-risk, frail cancer patients to ensure optical care is the focus of this month’s column.
The role of precision immunotherapy in treating solid tumors is summarized.
Clinical trial findings in the IDEA collaboration are summarized to determine possible duration of adjuvant chemotherapy in patients with stage III colon cancer.
More in this category
- Adjuvant therapies for biliary tract cancers
- Improving surgical care and outcomes through the OPTI-Surg toolkit
- Surgical management of ADH, ALH, and LCIS
- Clinical trials for surgeons: Hurdles and opportunities
- Present and future cancer staging with the eighth edition of the AJCC Cancer Staging Manual
- Induction chemotherapy and minimally invasive transanal surgery to increase organ preservation in rectal cancer
- Preventing colorectal adenomas in cancer survivors: An update on the PACES/S0820 trial
- ACS CRP sponsors educational sessions at Clinical Congress 2017
- Current role of immunotherapy in urologic cancers
- Gastrectomy for cancer: What are the benefits of a minimally invasive approach?
- ACS CRP Dissemination and Implementation Committee issues call for participants in pilot project
- Interventions to promote better conversations about initial treatment for prostate cancer
- Junior investigators: Get engaged in the Alliance for Clinical Trials in Oncology
- In search of the philosopher’s stone: The ALCHEMIST study for lung cancer
- A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy